KCNQ1 (Potassium Voltage-Gated Channel Subfamily Q Member 1)

A critical ion channel gene implicated in cardiac arrhythmias, deafness, and cancer susceptibility.

Gene Information Card

Symbol KCNQ1
Full Name Potassium voltage-gated channel subfamily Q member 1
Gene Type protein-coding
Chromosomal Location 11p15.5-p15.4
NCBI Gene ID 3784 ncbi.nlm.nih.gov/gene/3784
Ensembl ID ENSG00000053918
UniProt ID P51787
OMIM ID 607542
HGNC ID 6294
Aliases ATFB1, ATFB3, CLCN1, JLNS1, KCNA8, KCNA9, KVLQT1, LQT1, RWS

Description

KCNQ1 encodes the pore-forming alpha subunit of a voltage-gated potassium channel that is critical for cardiac repolarization, epithelial ion transport, and auditory function. The channel typically forms heterotetramers with KCNE accessory subunits. Mutations in KCNQ1 are associated with inherited cardiac arrhythmias, including long QT syndrome and short QT syndrome, as well as Jervell and Lange-Nielsen syndrome (deafness with arrhythmia). Altered KCNQ1 expression has also been implicated in certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Long QT syndrome 1 (LQT1) Loss-of-function mutations reduce cardiac IKs current, prolonging action potential duration and increasing risk of arrhythmia. ClinVar, OMIM
Jervell and Lange-Nielsen syndrome (JLNS) Homozygous or compound heterozygous loss-of-function mutations cause severe LQT and sensorineural deafness due to defective endolymph production. OMIM, ClinVar
Short QT syndrome 2 (SQT2) Gain-of-function mutations increase IKs current, shortening action potential duration and predisposing to atrial fibrillation and sudden death. OMIM, ClinVar
Atrial fibrillation (familial) Both gain- and loss-of-function mutations have been reported, leading to altered atrial refractoriness. OMIM, ClinVar
Type 2 diabetes (susceptibility) Common variants in KCNQ1 are associated with impaired insulin secretion, though the mechanism is not fully defined. NCBI, OMIM
Colorectal cancer (prognosis) KCNQ1 expression is often downregulated; loss of expression correlates with poor prognosis, possibly via effects on cell proliferation. COSMIC, literature

Expression Profile

Tissue Expression
Tissue nTPM level
Heart High (approx. 100 nTPM) Strong expression in cardiac muscle, especially ventricles.
Kidney Moderate (approx. 30 nTPM) Expressed in renal tubular epithelial cells.
Pancreas Moderate (approx. 20 nTPM) Expressed in pancreatic beta cells.
Lung Low (approx. 5 nTPM) Low expression in lung tissue.
Liver Low (approx. 3 nTPM) Minimal expression.
Cell Line Expression
Cell Line nTPM Notes
HEK293 Not determined Often used for heterologous expression studies.
HL-1 (cardiac myocyte) Not determined Endogenous expression; used for cardiac electrophysiology.
Caco-2 (colorectal) Moderate Expression correlates with differentiation.
MCF7 (breast cancer) Low Reduced expression compared to normal breast tissue.
A549 (lung cancer) Low Low expression; not a major site.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Arg518Ter (R518X) Nonsense Rare (founder mutation in some populations) Truncated protein; loss of function; causes LQT1.
p.Ala341Val (A341V) Missense Common in LQT1 cohorts Dominant-negative effect; reduces IKs current.
p.Gly314Ser (G314S) Missense Rare Loss of function; associated with JLNS when homozygous.
p.Val307Leu (V307L) Missense Rare Gain of function; associated with SQT2.
p.Arg231His (R231H) Missense Rare Loss of function; associated with atrial fibrillation.
Mutation functional classification

Loss of Function (LOF)

Most LQT1 mutations are loss-of-function, reducing IKs current amplitude or altering channel gating.

Gain of Function (GOF)

SQT2 mutations increase IKs current, shortening action potential duration.

Dominant Negative (DN)

Many LQT1 mutations exert dominant-negative effects, interfering with wild-type subunits in heterotetramers.

Gene Ontology (GO)

• voltage-gated potassium channel activity • delayed rectifier potassium channel activity
• protein homodimerization activity • protein heterodimerization activity
• plasma membrane • integral component of plasma membrane
• regulation of heart contraction • potassium ion transmembrane transport
• cellular response to hypoxia • auditory receptor cell differentiation

Pathways

Cardiac muscle contraction (KEGG hsa04260)
Adrenergic signaling in cardiomyocytes (KEGG hsa04261)
Cholinergic synapse (KEGG hsa04725)
Ion channel transport (Reactome R-HSA-983712)
Voltage gated potassium channels (Reactome R-HSA-1296072)

Protein Summary

The KCNQ1 protein (also known as KvLQT1) is a 676-amino acid voltage-gated potassium channel subunit. It contains six transmembrane domains (S1-S6) with a pore loop between S5 and S6. The functional channel is a tetramer, typically composed of four KCNQ1 subunits, and associates with KCNE1 (minK) to form the slow delayed rectifier potassium current (IKs) in cardiac myocytes. This current is crucial for phase 3 repolarization of the cardiac action potential. In the inner ear, KCNQ1/KCNE1 channels are essential for potassium secretion into the endolymph. Mutations affecting the protein's structure or function lead to channelopathies.

Related Products

Product name Cat.No. Species Gene ID
KCNQ1 Knockout HEK293 Cell Line EDJ-KQ2359 Human 3784 Details Get a Quote
KCNQ1 Knockout HCT 116 Cell Line EDJ-KQ22798 Human 3784 Details Get a Quote
KCNQ1 Knockout HeLa Cell Line EDJ-KQ22799 Human 3784 Details Get a Quote
KCNQ1 Knockout A-549 Cell Line EDJ-KQ62202 Human 3784 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: